NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
Application of luciferase assay for ATP to antimicrobial drug susceptibilityThe susceptibility of bacteria, particularly those derived from body fluids, to antimicrobial agents is determined in terms of an ATP index measured by culturing a bacterium in a growth medium. The amount of ATP is assayed in a sample of the cultured bacterium by measuring the amount of luminescent light emitted when the bacterial ATP is reacted with a luciferase-luciferin mixture. The sample of the cultured bacterium is subjected to an antibiotic agent. The amount of bacterial adenosine triphosphate is assayed after treatment with the antibiotic by measuring the luminescent light resulting from the reaction. The ATP index is determined from the values obtained from the assay procedures.
Document ID
19770015850
Acquisition Source
Legacy CDMS
Document Type
Other - Patent
Authors
Chappelle, E. W.
(NASA Goddard Inst. for Space Studies New York, NY, United States)
Picciolo, G. L.
(NASA Goddard Inst. for Space Studies New York, NY, United States)
Vellend, H.
(New England Medical Center Boston, United States)
Tuttle, S. A.
(New England Medical Center Boston, United States)
Barza, M. J.
(New England Medical Center Boston, United States)
Weinstein, L.
(New England Medical Center Boston, United States)
Date Acquired
August 8, 2013
Publication Date
March 29, 1977
Subject Category
Life Sciences (General)
Accession Number
77N22794
Distribution Limits
Public
Copyright
Work of the US Gov. Public Use Permitted.
Patent
NASA-CASE-GSC-12039-1|US-PATENT-4,014,745
Patent Application
US-PATENT-APPL-SN-572991
No Preview Available